Cheah CY, Chihara D, Romaguera JE, Fowler NH, Seymour JF, Hagemeister FB, Champlin RE, Wang ML. Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes. Ann Oncol.
2015 Jun;26(6):1175-9. doi: 10.1093/annonc/mdv111. PubMed PMID: 25712454.